Allelic imbalance at intragenic markers of Tbx18 is a hallmark of murine osteosarcoma

Carcinogenesis

Volumn 24, Issue 3, 2003, Pages 371-376

  Rosemann, M ^a,b   Kuosaite, V ^c   Nathrath, M ^a,b   Strom, T M ^a   Quintanilla Martinez, L ^a   Richter, T ^b   Imai, K ^a   Atkinson, M J ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Group for Biostatistics in Oncology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

T BOX TRANSCRIPTION FACTOR;

ALLELIC IMBALANCE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA FLANKING REGION; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; INTRON; MARKER GENE; MOUSE; NONHUMAN; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

ALLELES; ANIMALS; BASE SEQUENCE; BONE NEOPLASMS; CHROMOSOME MAPPING; DNA PRIMERS; FEMALE; GENETIC MARKERS; HUMANS; HYBRID CELLS; INTRONS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; OSTEOSARCOMA; SEQUENCE TAGGED SITES; TRANSCRIPTION FACTORS;

EID: 0344406233     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/24.3.371     Document Type: Article

References (34)

1. Tarkkanen,M., Karhu,R., Kallioniemi,A., Elomaa,I., Kivioja,A.H., Nevalainen,J., Bohling,T., Karaharju,E., Hyytinen,E. and Knuutila,S. (1995) Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res., 55, 1334-1338.
2. Bridge,J.A., Nelson,M., McComb,E., McGuire,M.H., Rosenthal,H., Vergara,G., Maale,G.E., Spanier,S. and Neff,J.R. (1997) Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet. Cytogenet., 95, 74-87.
3. Radig,K., Schneider-Stock,R., Mittler,U., Neumann,H.W. and Roessner,A. (1998) Genetic instability in osteoblastic tumors of the skeletal system. Pathol. Res. Pract., 194, 669-677.
4. Yamaguchi,T., Toguchida,J., Yamamuro,T., Kotoura,Y., Takada,N., Kawaguchi,N., Kaneko,Y., Nakamura,Y., Sasaki,M.S. and Ishizaki,K. (1992) Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res., 52, 2419-2423.
5. Miller,C.W., Aslo,A., Campbell,M.J., Kawamata,N., Lampkin,B.C. and Koeffler,H.P. (1996) Alterations of the p15, p16, and p18 genes in osteosarcoma. Cancer Genet. Cytogenet., 86, 136-142.
6. Miller,C.W., Aslo,A., Won,A., Tan,M., Lampkin,B. and Koeffler,H.P. (1996) Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J. Cancer Res. Clin. Oncol., 122, 559-565.
7. Benassi,M.S., Molendini,L., Gamberi,G., Ragazzini,P., Sollazzo,M.R., Merli,M., Asp,J., Magagnoli,G., Balladelli,A., Bertoni,F. and Picci,P. (1999) Alteration of pRb/p16/cdk4 regulation in human osteosarcoma. Int. J. Cancer, 84, 489-493.
8. Grundmann,E., Ueda,Y., Schneider-Stock,R. and Roessner,A. (1995) New aspects of cell biology in osteosarcoma. Pathol. Res. Pract., 191, 563-570.
9. Masuda,H., Miller,C., Koeffler,H.P., Battifora,H. and Cline,M.J. (1987) Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl Acad. Sci. USA, 84, 7716-7719.
10. Miller,C.W., Aslo,A., Tsay,C., Slamon,D., Ishizaki,K., Toguchida,J., Yamamuro,T., Lampkin,B. and Koeffler,H.P. (1990) Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res., 50, 7950-7954.
11. Toguchida,J., Yamaguchi,T., Ritchie,B., Beauchamp,R.L., Dayton,S.H., Herrera,G.E., Yamamuro,T., Kotoura,Y., Sasaki,M.S. and Little,J.B. (1992) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res., 52, 6194-6199.
12. Nellissery,M.J., Padalecki,S.S., Brkanac,Z., Singer,F.R., Roodman,G.D., Unni,K.K., Leach,R.J. and Hansen,M.F. (1998) Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. Am. J. Hum. Genet., 63, 817-824.
13. Anderson,D.M., Maraskovsky,E., Billingsley,W.L., Dougall,W.C., Tometsko,M.E., Roux,E.R., Teepe,M.C., DuBose,R.F., Cosman,D. and Galibert,L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature, 390, 175-179.
14. Nakagawa,N., Kinosaki,M., Yamaguchi,K., Shima,N., Yasuda,H., Yano,K., Morinaga,T. and Higashio,K. (1998) RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Commun., 253, 395-400.
15. Nathrath,M., Kuosaite,V., Rosemann,M., Kremer,M., Poremba,C., Wakana,S., Yanagi,M., Natrath,W.B., Hoefler,H., Imai,K. and Atkinson,M.J. (2002) Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalance in mouse and man. Oncogene, 21, 5975-5980.
16. Luz,A., Muller,W.A., Linzner,U., Strauss,P.G., Schmidt,J., Muller,K., Atkinson,M.J., Murray,A.B., Gossner,W., Erfle,V. and Hoefler,H. (1991) Bone tumor induction after incorporation of short-lived radionuclides. Radiat. Environ. Biophys., 30, 225-227.
17. Rosemann,M., Lintrop,M., Favor,J. and Atkinson,M.J. (2002) Bone tumorigenesis induced by alpha-particle radiation: mapping of genetic loci influencing predisposition in mice. Radiat. Res., 157, 426-434.
18. Manly,K.F. and Olson,J.M. (1999) Overview of QTL mapping software and introduction to Map Manager QT. Mamm. Genome, 10, 327-334.
19. Dietrich,W.F., Miller,J.C., Steen,R.G., Merchant,M., Damron,D., Nahf,R., Gross,A., Joyce,D.C., Wessel,M., Dredge,R.D. et al (1994) A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nature Genet., 7, 220-245.
20. Kraus,F., Haenig,B. and Kispert,A. (2001) Cloning and expression analysis of the mouse T-box gene Tbx18. Mech. Dev., 100, 83-86.
21. Yandell,D.W., Dryja,T.P. and Little,J.B. (1986) Somatic mutations at a heterozygous autosomal locus in human cells occur more frequently by allele loss than by intragenic structural alterations. Somat. Cell Mol. Genet., 12, 255-263.
22. Li,C.Y., Yandell,D.W. and Little,J.B. (1992) Molecular mechanisms of spontaneous and induced loss of heterozygosity in human cells in vitro. Somat. Cell Mol. Genet., 18, 77-87.
23. Evans,H.H. (1994) Failla Memorial Lecture. The prevalence of multilocus lesions in radiation-induced mutants. Radiat. Res., 137, 131-144.
24. Hei,T.K., Piao,C.Q., Willey,J.C., Thomas,S. and Hall,E.J. (1994) Malignant transformation of human bronchial epithelial cells by radon-simulated alpha-particles. Carcinogenesis, 15, 431-447.
25. Bouffler,S.D., Breckon,G. and Cox,R. (1996) Chromosomal mechanisms in murine radiation acute myeloid leukaemogenesis. Carcinogenesis, 17, 655-669.
26. Papaioannou,V.E. and Silver,L.M. (1998) The T-box gene family. Bioessays, 20, 9-19.
27. Smith,J. (1997) Brachyury and the T-box genes. Curr. Opin. Genet. Dev., 7, 474-480.
28. Jacobs,J.J., Keblusek,P., Robanus-Maandag,E., Kristel,P., Lingbeek,M., Nederlof,P.M., van Welsem,T., van de Vijver,M.J., Koh,E.Y., Daley,G.Q. and van Lohuizen,M. (2000) Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nature Genet., 26, 291-299.
29. Hatcher,C.J., Kim,M.S., Mah,C.S., Goldstein,M.M., Wong,B., Mikawa,T. and Basson,C.T. (2001) TBX5 transcription factor regulates cell proliferation during cardiogenesis. Dev. Biol., 230, 177-188.
30. Chen,J., Zhong,Q., Wang,J., Cameron,R.S., Borke,J.L., Isales,C.M. and Bollag,R.J. (2001) Microarray analysis of Tbx2-directed gene expression: a possible role in osteogenesis. Mol. Cell Endocrinol., 177, 43-54.
31. Knudson,A.G. Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA, 68, 820-823.
32. Esteller,M. (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 35, 5427-5440.
33. Shiraishi,M., Sekiguchi,A., Terry,M.J., Oates,A.J., Miyamoto,Y., Chuu,Y.H., Munakata,M. and Sekiya,T (2002) A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for the identification of tumor suppressor genes. Oncogene, 21, 3804-3813.
34. Islam,M.Q. and Islam,K. (2000) A new functional classification of tumor-suppressing genes and its therapeutic implications. Bioessays, 22, 274-285.